Detection of tumor-specific mRNA in cell-free bronchial lavage supernatant in patients with lung cancer

被引:6
作者
Engel, E
Schmidt, B
Carstensen, T
Weickmann, S
Jandrig, B
Witt, C
Fleischhacker, M
机构
[1] Univ Med Berlin, Charite, Med Klin 2, Mol Biol Lab, D-10117 Berlin, Germany
[2] Univ Med Berlin, Charite, Med Klin 1, D-10117 Berlin, Germany
[3] Max Delbruck Ctr Mol Med, D-13122 Berlin, Germany
来源
CIRCULATING NUCLEIC ACIDS IN PLASMA/SERUM III AND SERUM PROTEOMICS | 2004年 / 1022卷
关键词
cell-free mRNA; plasma; tumor; bronchial lavage; supernatant; lung; cancer;
D O I
10.1196/annals.1318.023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bronchoscopy is a standard procedure in the workup of patients with suspicious pulmonary lesions. We wondered whether it is possible to isolate malignancy-associated mRNA from cell-free lavage supernatant. Extracellular mRNA from cell-free lavage supernatant of 25 patients with lung cancer (23 with non-small cell lung cancer, 2 with small cell lung cancer) was isolated, reverse-transcribed, and amplified by reverse transcriptase polymerase chain reaction. The quantity and quality of the isolated RNA were checked after cDNA synthesis by amplification with P-actin-specific primers. Afterwards, a panel of eight genes known to be expressed in lung tumors was used for the detection of tumor-associated mRNA expression in lavage supernatant and serum. mRNA coding for P-actin could be isolated from lavage supernatant of all 25 patients. In addition, the expression of at least one tumor-associated gene was detectable in all patients. These results show that intact mRNA can be isolated from cell-free lavage supernatant and that its quantity and quality are sufficient for the detection of tumor-associated gene expression alterations. This may open new possibilities for the diagnosis of lung cancer.
引用
收藏
页码:140 / 146
页数:7
相关论文
共 14 条
[1]  
Brabender J, 2001, CLIN CANCER RES, V7, P1850
[2]  
Bruhn N, 2000, ANN NY ACAD SCI, V906, P72
[3]   Detection of telomerase activity in bronchial lavage as an adjunct to cytological diagnosis in lung cancer [J].
Dikmen, E ;
Kara, M ;
Dikmen, G ;
Çakmak, H ;
Dogan, P .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2003, 23 (02) :194-199
[4]  
Fleischhacker M, 2001, ANN NY ACAD SCI, V945, P179
[5]  
Hamasaki M, 2001, ANTICANCER RES, V21, P979
[6]  
Hibi K, 1998, CANCER RES, V58, P5690
[7]   Role of biomarkers for early detection of lung cancer and chemoprevention [J].
Hirsch, FR ;
Merrick, DT ;
Franklin, WA .
EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (06) :1151-1158
[8]  
Jang SJ, 2001, CANCER RES, V61, P7959
[9]  
Kopreski MS, 1999, CLIN CANCER RES, V5, P1961
[10]  
Pihan GA, 1998, CANCER RES, V58, P3974